Scynexis' IPO

Scynexis raised a round of funding on May 02, 2014. Investors include Public.

Scynexis is a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs. The company is developing it…

Articles about Scynexis' IPO: